Thursday, October 2, 2025
HomeTagsAntibody therapeutics

antibody therapeutics

Genmab Strengthens Oncology Pipeline with Acquisition of Merus

Genmab has entered into a binding agreement to acquire Merus, with both companies’ boards unanimously approving the transaction, which is expected to close in...

Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer

Dren Bio, Inc, a privately held, clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune, and other serious diseases, announced that it has entered...

Ability Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators

Ability Biologics announced the final closing of its seed funding, raising a total of $18 million (US), a financing round led by founding investor Amplitude...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics